Stockscreener 앱 받기
0.0575
42.50%
-0.0425
시간 외 거래:
.06
0.0025
+4.35%
전일 마감가:
$0.10
열려 있는:
$0.0676
하루 거래량:
413.42K
Relative Volume:
0.35
시가총액:
$697.73K
수익:
-
순이익/손실:
$-48.85M
주가수익비율:
-0.0249
EPS:
-2.31
순현금흐름:
$-46.25M
1주 성능:
-79.09%
1개월 성능:
-90.09%
6개월 성능:
-99.24%
1년 성능:
-99.68%
1일 변동 폭
$0.0451
$0.084
1주일 범위
$0.0451
$0.2185
52주 변동 폭
$0.0451
$18.70
Vincerx Pharma Inc Stock (VINC) Company Profile
VINC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VINC
Vincerx Pharma Inc
|
0.0575 | 697.73K | 0 | -48.85M | -46.25M | -2.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-14 | 개시 | H.C. Wainwright | Buy |
| 2021-12-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-01 | 개시 | SVB Leerink | Outperform |
| 2021-09-13 | 개시 | Laidlaw | Buy |
| 2021-08-25 | 개시 | B. Riley Securities | Buy |
Vincerx Pharma Inc 주식(VINC)의 최신 뉴스
Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com
Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX
Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com
Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister
Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga
The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com
VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa
VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India
Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa
Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView
Vincerx Pharma announces plan to delist from Nasdaq - TipRanks
Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World
vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia
vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India
Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga
Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada
Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals
Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks
Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times
Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com
Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener
Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa
Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World
Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView
Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register
Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire
VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK
Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI -March 18, 2025 at 09:40 am EDT - Marketscreener.com
Vincerx Pharma plans reverse merger with QumulusAI - Investing.com India
Vincerx Pharma Inc (VINC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
36.06%
자본화:
|
볼륨(24시간):